Daniela Sambataro
Author
Alternate names D. Sambataro, Daniela Sambataro
Institution Università degli Studi di Enna Kore
Past institutions Ospedali Riuniti Umberto I, Università degli Studi di Enna Kore, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Ospedale Garibaldi, Ospedale per gli Infermi +3 more
ORCID: Yes
H-index: 10
I10-index: 10
Works count: 37
Citations count: 596
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial
2015 · Sandro Pignata, Domenica Lorusso, et al. · The Lancet Oncology
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
2021 · Sandro Pignata, Domenica Lorusso, et al. · The Lancet Oncology
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.
1999 · Vittorio Gebbia, A. C. Testa, et al. · PubMed